Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A sensitivity analysis focused only on four studies reporting adjusted effect estimates, including 793 exposed and 488,871 comparator pregnancies, produced similar findings (OR 1.40
Outcomes observed in Phase 2 trials under carefully controlled conditions may differ from those seen in real-world clinical practice
Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
Younger adults were the most aware Adults aged 18-24 reported the highest awareness levels, with more than a quarter ( 25.92% ) saying they knew about the upcoming launch
US$ 28.77
US$ 23.00
US$ 23.70
US$ 29.96
US$ 20.35
